---

---

symbols : Azn   

save search

---

Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
Published: 2023-05-23 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| -5.14% | O: 0.7% H: 1.22% C: -0.67%
NVO | News | $128.64 2.7% -0.07% 3.7M |

Health Technology

| -24.56% | O: -1.39% H: 0.06% C: -2.77%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -4.6% | O: 0.15% H: 0.74% C: -0.18%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| 70.29% | O: -0.25% H: 0.69% C: -2.24%
ABT | News | $107.59 0.49% -0.09% 3.8M |

Health Technology

| -0.61% | O: -0.88% H: 0.17% C: -1.45%
ORMP A | $2.39 2.58% 2.51% 31K |

Health Technology

| -46.95% | O: 0.9% H: 10.29% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| -4.84% | O: 0.97% H: 0.0% C: -1.46%
report global protein therapeutics growth market

---

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $176.0 -19.21% 50 |

n/a

| -10.35% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $89.17 3.3% 54K |

n/a

| -8.42% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 7.76% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $574.59 4.78% -1.12% 2.5M |

Health Technology

| 1.24% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $13.01 1.01% 0.0% 8.9M |

Health Technology

| 31.28% | O: -1.21% H: 0.43% C: -3.58%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -14.67% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $30.49 1.43% 0.0% 1.1M |

Health Technology

| -17.51% | O: 0.76% H: 1.91% C: 1.26%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| 19.71% | O: 0.32% H: 0.17% C: -1.53%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| 131.71% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $56.03 -0.04% 0.0% 1.5M |

Health Technology

| -21.46% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -28.9% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $114.21 1.71% 0.0% 1.7M |

Process Industries

| -55.54% | O: -0.95% H: 1.02% C: -2.19%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 9.18% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -1.4% | O: 0.65% H: 0.0% C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M |

Health Technology

| -17.36% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -28.52% | O: 0.28% H: 0.0% C: -2.26%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 9.74% | O: 0.9% H: 0.28% C: -1.3%
global report market

---

Regenerative Medicine Market to be Worth $180.87 Billion by 2030: Grand View Research, Inc.
Published: 2023-02-14 (Crawled : 10:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 0.73% | O: 0.43% H: 1.52% C: -1.88%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| 32.07% | O: 0.34% H: 0.0% C: 0.0%
USRM | $0.0001 1300.0% 290K |

Professional, Scientific, and T...

| -97.78% | O: 2.22% H: 4.35% C: 4.35%
PFE | News 4 | $26.32 0.23% 0.0% 24M |

Health Technology

| -40.17% | O: 0.23% H: 0.25% C: -0.84%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 13.0% | O: 0.27% H: 0.42% C: -0.21%
LLY | News | $745.69 1.96% -0.16% 2M |

Health Technology

| 110.92% | O: 0.04% H: 0.93% C: -0.85%
NUVA | $39.75 -2.24% -2.29% 0 |

Health Technology

| -10.15% | O: -0.16% H: 2.24% C: 0.79%
MDXG | $6.505 2.28% 2.23% 750K |

Health Technology

| 40.91% | O: -1.3% H: 2.85% C: 2.19%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 1.64% | O: 0.3% H: 0.94% C: 0.6%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| 12.26% | O: -0.39% H: 0.12% C: -0.69%
market

---

Global Opioids Market to 2027 - Size, Share & Industry Trends Analysis Report
Published: 2022-06-24 (Crawled : 21:00) - prnewswire.com
ENDP | News | $0.2926 -9.6% |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
MNKKQ | $0.02 |

Manufacturing

| Email alert Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| Email alert Add to watchlist
PFE | News 4 | $26.32 0.23% 0.0% 24M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K |

n/a

| Email alert Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| Email alert Add to watchlist
trends report market

---

Neuropathy Pain Treatment Market Size to Grow by USD 3.81 Bn, Growing Focus on Emerging Economies to be a Key Trend - Technavio
Published: 2022-10-04 (Crawled : 11:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K |

n/a

| -95.63% | O: -1.75% H: 17.22% C: 10.78%
ALPMF | News | $9.75 43.47% 200 |

Health Technology

| -26.7% | O: 5.79% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 23.75% | O: 8.97% H: 0.0% C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 26.11% | O: 0.45% H: 2.01% C: 1.12%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -29.13% | O: 1.34% H: 1.11% C: 1.11%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 28.94% | O: 1.37% H: 1.04% C: 0.66%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| 36.33% | O: 1.59% H: 0.93% C: -0.07%
BAX | $41.02 1.54% 0.0% 2.6M |

Health Technology

| -26.25% | O: 0.99% H: 2.56% C: 2.28%
ABT | News | $107.59 0.49% -0.09% 3.8M |

Health Technology

| 8.11% | O: 1.23% H: 2.45% C: 2.32%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| 21.7% | O: 2.72% H: 0.0% C: 0.0%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -26.91% | O: 0.64% H: 1.45% C: 0.55%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 27.54% | O: 1.42% H: 1.38% C: 1.24%
treatment growing market

---

Opioid Induced Constipation (OIC) Drugs Market to Reach USD 1.79 billion, Globally, by 2031 at 4.9% CAGR: Allied Market Research
Published: 2023-02-24 (Crawled : 16:00) - prnewswire.com
MNK | $0.3402 -0.06% 540K |

n/a

| -95.41% | O: 6.42% H: 0.04% C: -4.87%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 4.13% | O: -1.25% H: 0.59% C: 0.59%
TAK | News | $13.38 0.15% 0.9% 1.7M |

Health Technology

| -15.64% | O: -2.47% H: 0.0% C: -0.32%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 14.24% | O: -0.25% H: 0.03% C: -0.81%
BHC | $8.53 0.95% 0.0% 4M |

Health Technology

| -13.4% | O: -0.81% H: 1.28% C: -2.05%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 5.12% | O: -0.98% H: 0.16% C: -0.55%
research opioid market

---

Neuroimmunology Drugs Market worth $37.32 billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-07-06 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 12.53% | O: 9.36% H: 0.0% C: -4.54%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 18.13% | O: -0.11% H: 0.5% C: 0.16%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -16.29% | O: -0.48% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -5.97% | O: -0.28% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 9.45% | O: 2.15% H: 0.79% C: 0.56%
report market drug

---

Global Bioengineered Protein Drugs Markets Report 2023: A $521.3 Billion Market by 2027 Featuring AbbVie, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, Merck and Sanofi
Published: 2023-04-20 (Crawled : 01:00) - prnewswire.com
CMXHF | $176.0 -19.21% 50 |

n/a

| -12.22% | O: -1.07% H: 1.56% C: -0.01%
CSLLY | $89.17 3.3% 54K |

n/a

| -9.87% | O: 0.23% H: 0.39% C: -0.18%
GLAXF | News | $20.305 -14.18% 630 |

Health Technology

| 5.62% | O: -0.08% H: 0.0% C: -0.68%
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| -5.06% | O: 0.42% H: 0.0% C: -0.53%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| 17.55% | O: 0.61% H: 0.0% C: 0.0%
NVO | News | $128.64 2.7% -0.07% 3.7M |

Health Technology

| -22.05% | O: 0.33% H: 0.36% C: -0.13%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 0.86% | O: 0.34% H: 0.28% C: 0.25%
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -7.92% | O: -0.06% H: 0.86% C: 0.71%
GSK | News | $41.24 1.6% 0.0% 2.3M |

Health Technology

| 11.67% | O: -0.24% H: 0.0% C: -1.03%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 5.17% | O: -0.02% H: 0.37% C: 0.35%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -15.45% | O: -0.03% H: 0.0% C: 0.0%
BNTX | News | $88.53 0.59% 0.59% 360K |

Health Technology

| -27.34% | O: -0.85% H: 1.51% C: 0.15%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| -5.33% | O: 0.05% H: 0.11% C: -0.47%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| 11.1% | O: -0.04% H: 0.11% C: -1.08%
ADMA 4 | $6.535 5.4% 5.13% 2.7M |

Health Technology

| 89.02% | O: -0.87% H: 1.17% C: 0.29%
report merck global protein sanofi market

---

Innate Pharma: First Patient Dosed in Monalizumab Phase 3 Lung Cancer Clinical Trial Triggers $50M Payment From AstraZeneca
Published: 2022-04-29 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -9.81% | O: 0.48% H: 0.24% C: 0.24%
NVO | News | $128.64 2.7% -0.07% 3.7M |

Health Technology

| 19.09% | O: 5.98% H: 1.44% C: -0.42%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -10.97% | O: 1.93% H: 0.0% C: 0.0%
IPHA | $2.425 -7.02% 2.7K |

Health Technology

| -12.22% | O: 11.11% H: 3.67% C: -4.33%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 7.54% | O: 0.53% H: 2.37% C: 0.26%
trial payment cancer phase 3

---

Innate Pharma Provides Update on AstraZeneca-Sponsored INTERLINK-1 Phase 3 Study
Published: 2022-08-01 (Crawled : 10:00) - biospace.com/
IPHYF | $2.65 104.6% 300 |

Health Technology

| -16.14% | O: -14.87% H: 4.09% C: 4.09%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -6.63% | O: -3.9% H: 0.0% C: 0.0%
NVO | News | $128.64 2.7% -0.07% 3.7M |

Health Technology

| 9.77% | O: -0.21% H: 0.41% C: -0.73%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -5.84% | O: -1.92% H: 0.0% C: 0.0%
IPHA | $2.425 -7.02% 2.7K |

Health Technology

| -25.94% | O: -11.25% H: 0.0% C: -1.06%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 6.98% | O: 0.44% H: 0.53% C: -1.31%
pharma update study

---

Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300 |

Health Technology

| -12.54% | O: 1.65% H: 0.0% C: -0.32%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -11.71% | O: -0.94% H: 0.0% C: 0.0%
NVO | News | $128.64 2.7% -0.07% 3.7M |

Health Technology

| 15.37% | O: 0.65% H: 0.63% C: 0.16%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -12.28% | O: -0.09% H: 0.0% C: 0.0%
IPHA | $2.425 -7.02% 2.7K |

Health Technology

| -19.99% | O: 2.96% H: 0.98% C: -1.15%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 6.56% | O: -0.56% H: 0.82% C: -0.64%
iph5201 pharma cancer phase 2

---

Hairy Cell Leukemia Therapeutics Market Size to Grow by USD 177.85 million, Majority of Growth to Originate from North America - Technavio
Published: 2022-08-22 (Crawled : 07:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 6.98% | O: 2.39% H: 1.09% C: 1.09%
VTRS | News A | $11.36 0.98% 0.97% 4.7M |

Health Technology

| 7.47% | O: -0.66% H: 0.1% C: -1.43%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 19.52% | O: 0.08% H: 0.49% C: -1.15%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 5.48% | O: 0.49% H: 1.11% C: -0.39%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| 9.04% | O: -0.35% H: 0.5% C: -1.23%
america leukemia therapeutics growth market

---

Liver Cancer Drugs Market - 42% of Growth to Originate from North America | Evolving Opportunities with AstraZeneca Plc & Bayer AG| 17000+ Technavio Reports
Published: 2022-03-30 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 3.08% | O: -5.22% H: 6.2% C: 1.91%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -100.0% | O: 0.0% H: 0.0% C: -15.0%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 12.97% | O: 0.58% H: 0.56% C: -0.07%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 7.43% | O: 0.42% H: 1.49% C: 1.34%
america liver cancer growth market

---

Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published: 2022-06-21 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 16.7% | O: 6.34% H: 0.0% C: -4.65%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| 46.1% | O: 4.65% H: 0.0% C: -4.51%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -100.0% | O: 46.85% H: 0.0% C: -30.95%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 21.32% | O: 1.41% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 15.75% | O: 2.03% H: 0.0% C: 0.0%
research liver cancer market

---

Liver cancer drugs market size to grow by USD 5.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
Published: 2023-02-09 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 9.6% | O: 6.07% H: 1.75% C: 0.35%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -99.98% | O: -4.0% H: 4.17% C: 4.17%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 13.78% | O: 0.87% H: 0.17% C: -1.53%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 10.08% | O: 6.13% H: 0.42% C: -1.3%
liver cancer market

---

Liver Cancer Drugs Market size to grow at a CAGR of 14.67% from 2021 to 2026, Driven by the growing incidence of liver cancer - Technavio
Published: 2023-04-12 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| -1.72% | O: 5.41% H: 0.0% C: -2.14%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| 20.94% | O: 1.1% H: 0.0% C: 0.0%
QBIO | $0.0002 100.0% 1.1K |

Professional, Scientific, and T...

| -99.99% | O: 0.0% H: 3.57% C: 3.57%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 3.19% | O: 0.75% H: 0.5% C: -0.05%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| -1.84% | O: 1.96% H: 0.71% C: 0.22%
liver cancer growing market

---

Global MRSA Drugs Markets, 2017-2022, 2022-2027F, 2032F: Focus on Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, & Lipoglycopeptide
Published: 2023-09-08 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 4.17% | O: 0.86% H: 0.0% C: -0.1%
IPIX | $0.0042 92.86% 1.4K |

Manufacturing

| -40.48% | O: 0.0% H: 1.19% C: 0.6%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 13.85% | O: 0.07% H: 0.0% C: 0.0%
CPIX | $1.63 0.62% 0.61% 6.8K |

Health Technology

| -1.8% | O: -2.99% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 4.19% | O: 0.49% H: 0.24% C: -0.16%
global

---

InteRNA Technologies Establishes Clinical Advisory Board and Appoints New Members to Scientific Advisory Board
Published: 2021-10-19 (Crawled : 10:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 16.8% | O: -1.76% H: 2.93% C: 1.16%
GLPG | News | $29.47 1.38% 1.36% 120K |

Health Technology

| -43.5% | O: -0.33% H: 2.39% C: 1.79%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 19.5% | O: 0.46% H: 1.56% C: 1.02%

---

Idiopathic Pulmonary Fibrosis Market to Reach $6.16 Bn, Globally, by 2030 at 7.0% CAGR: Allied Market Research
Published: 2022-02-07 (Crawled : 13:30) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 26.93% | O: 2.69% H: 0.5% C: -1.76%
BMY | $48.99 -0.31% 0.0% 9.1M |

Health Technology

| -22.3% | O: 3.7% H: 1.64% C: 1.24%
GLPG | News | $29.47 1.38% 1.36% 120K |

Health Technology

| -55.14% | O: 2.54% H: 1.58% C: 0.1%
FGEN | $1.07 -6.14% -6.54% 1.3M |

Health Technology

| -92.71% | O: -1.09% H: 9.3% C: 8.82%
BIIB | $193.18 -0.48% -0.48% 1.4M |

Health Technology

| -10.25% | O: 2.54% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 25.91% | O: -0.14% H: 1.01% C: 0.87%
fibrosis research

---

JAK Inhibitors Market to Grow by USD 12.05 billion | Increasing Number of Awareness Campaigns to Boost Growth | Technavio
Published: 2022-03-01 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K |

Health Technology

| 15.0% | O: 0.37% H: 2.02% C: 2.02%
NVSEF | News | $95.11 6.88% 490 |

Health Technology

| 10.85% | O: 1.39% H: 0.0% C: 0.0%
ALPMY | News | $9.53 -1.11% 690K |

Manufacturing

| -41.78% | O: -1.17% H: 0.68% C: 0.68%
NVS | News | $97.28 2.27% 0.31% 3.7M |

Health Technology

| 12.16% | O: -1.55% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| 14.54% | O: -0.22% H: 2.4% C: 1.27%
GLPG | News | $29.47 1.38% 1.36% 120K |

Health Technology

| -56.73% | O: -2.66% H: 0.35% C: -1.83%
CTIC | $9.09 0.05% 11M |

Health Technology

| 222.52% | O: 6.03% H: 13.88% C: 12.71%
AZN | News | $70.85 1.03% 1.02% 5.6M |

Health Technology

| 13.79% | O: -0.62% H: 0.0% C: 0.0%
growth

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 1.1M |

HKIT | $1.345 31.86% 24.16% 390K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---